Annexon, Inc. (ANNX) Earnings Call Transcript & Summary

Welcome to the Annexon 2021 Annual Meeting of Stockholders. Mr. Love, you may now begin.

Thank you. Good morning. I am Douglas Love, President and CEO of Annexon Biosciences. I'm very happy to welcome you to an Annexon's 2021 Annual Meeting of Stockholders. Here to at Annexon, we've made significant progress toward our goal of building a leading complement company. And every day, we're sharply focused on advancing our mission to deliver transformative therapies for patients with complement-driven autoimmune and neurodegenerative diseases. We are conducting our annual meeting virtually. Before I call the meeting to order, I'd like to introduce to you the members of the Board and the business team who are present online with us today. The members of the Board participating online today are Tom Wiggans, Chairman of the Board; William Carson; Jung Choi; Muneer Satter; Ricky Sun; and myself, Douglas Love. The other members of the company's leadership team joining us online today are Ms. Jennifer Lew, Executive Vice President and Chief Financial Officer and Secretary of Annexon. I would also like to introduce you to Katie Wechsler of KPMG LLP, the company's independent registered public accounting firm as well as Kathleen Wells of Latham & Watkins LLP, the company's outside legal counsel, both of whom are joining us online today. We have made available both the agenda for this meeting and certain operating procedures under the materials button on the bottom right-hand side of your computer screen. In order to conduct an orderly meeting, we ask that participants abide by these procedures, and we appreciate your cooperation in this matter. The meeting will now officially come to order. We will proceed with the formal business of the meeting as set forth in your notice of annual meeting and proxy statement. After the formal part of the meeting, we will provide time for appropriate questions. Will the Secretary please report at this time with respect to the stockholders' list and the mailing of the notice of the meeting.

I have a complete list of the stockholders of record of the company's common stock on April 5, 2021, the record date for this meeting. This list of stockholders and the number of shares held by each such stockholder as of the record date is available on the web portal for any stockholder wishing to inspect it. An affidavit has been delivered, certifying that on or about April 23, 2021, a notice of Annual Meeting of Stockholders of the company was deposited in the U.S. mail to all stockholders of record at the close of business on April 5, 2021.

At this time, I'd like to introduce [ Wendy Shiba ], acting as Inspector of Election at this meeting. [ Ms. Shiba ] has taken and subscribed customary oath of office to execute her duties with strict impartiality, and we will file this note with the records of the meeting. Will the Secretary please report at this time with respect to the existence of a quorum.

I have been informed by the Inspector of Election that proxies have been received for 28,185,464 of the 38,240,150 shares of common stock outstanding on the record date, which represents approximately 74% of the total number of outstanding shares. This constitutes a quorum for the meeting today, and we may now carry out the official business of the meeting.

Thank you. We will now proceed with the formal business of this meeting. There are 2 proposals to be considered by the stockholders at this meeting.

The polls opened today, Wednesday, June 2, 2021, at 9:00 a.m. Pacific Time for voting on all matters to be presented. The polls will be closed to voting after we go through the matters to be voted on.